JP2024084670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024084670A5 JP2024084670A5 JP2023090210A JP2023090210A JP2024084670A5 JP 2024084670 A5 JP2024084670 A5 JP 2024084670A5 JP 2023090210 A JP2023090210 A JP 2023090210A JP 2023090210 A JP2023090210 A JP 2023090210A JP 2024084670 A5 JP2024084670 A5 JP 2024084670A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- migalastat
- salt
- patient
- caffeine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025169972A JP2026031546A (ja) | 2022-12-13 | 2025-10-08 | ミガラスタットの薬物動態を改善する方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263432235P | 2022-12-13 | 2022-12-13 | |
| US63/432,235 | 2022-12-13 | ||
| US18/315,928 | 2023-05-11 | ||
| US18/315,928 US20240197706A1 (en) | 2022-12-13 | 2023-05-11 | Methods of improving the pharmacokinetics of migalastat |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169972A Division JP2026031546A (ja) | 2022-12-13 | 2025-10-08 | ミガラスタットの薬物動態を改善する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024084670A JP2024084670A (ja) | 2024-06-25 |
| JP2024084670A5 true JP2024084670A5 (https=) | 2025-04-23 |
| JP7757345B2 JP7757345B2 (ja) | 2025-10-21 |
Family
ID=86646511
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023090210A Active JP7757345B2 (ja) | 2022-12-13 | 2023-05-31 | ミガラスタットの薬物動態を改善する方法 |
| JP2025169972A Pending JP2026031546A (ja) | 2022-12-13 | 2025-10-08 | ミガラスタットの薬物動態を改善する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169972A Pending JP2026031546A (ja) | 2022-12-13 | 2025-10-08 | ミガラスタットの薬物動態を改善する方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20240197706A1 (https=) |
| EP (2) | EP4385509B1 (https=) |
| JP (2) | JP7757345B2 (https=) |
| KR (1) | KR20240094973A (https=) |
| AU (1) | AU2023396459A1 (https=) |
| CA (1) | CA3201512A1 (https=) |
| CL (1) | CL2025001743A1 (https=) |
| CO (1) | CO2025009079A2 (https=) |
| DE (1) | DE202023003007U1 (https=) |
| DK (1) | DK4385509T3 (https=) |
| ES (1) | ES3055214T3 (https=) |
| FI (1) | FI4385509T3 (https=) |
| HR (1) | HRP20251472T1 (https=) |
| IL (1) | IL321404A (https=) |
| LT (1) | LT4385509T (https=) |
| MX (1) | MX2025006897A (https=) |
| PL (1) | PL4385509T3 (https=) |
| PT (1) | PT4385509T (https=) |
| RS (1) | RS67478B1 (https=) |
| SI (1) | SI4385509T1 (https=) |
| SM (1) | SMT202500453T1 (https=) |
| TW (1) | TW202423436A (https=) |
| WO (1) | WO2024129220A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| MX2009010557A (es) | 2007-03-30 | 2009-11-19 | Amicus Therapeutics Inc | Metodo para el tratamiento de la enfermedad de fabry que utiliza chaperonas farmacologicas. |
| US9999618B2 (en) * | 2007-04-26 | 2018-06-19 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
| EP2946785B1 (en) | 2008-02-12 | 2018-10-24 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
| SG10201604757RA (en) * | 2011-03-11 | 2016-08-30 | Amicus Therapeutics Inc | Dosing regimens for the treatment of fabry disease |
| EP4426846A4 (en) * | 2021-11-03 | 2025-11-05 | Sangamo Therapeutics Inc | METHODS OF USING VIRAL VECTOR CONSTRUCTIONS FOR THE TREATMENT OF FABRY DISEASE |
-
2023
- 2023-05-11 US US18/315,928 patent/US20240197706A1/en active Pending
- 2023-05-31 HR HRP20251472TT patent/HRP20251472T1/hr unknown
- 2023-05-31 CA CA3201512A patent/CA3201512A1/en active Pending
- 2023-05-31 EP EP23176366.5A patent/EP4385509B1/en active Active
- 2023-05-31 RS RS20251212A patent/RS67478B1/sr unknown
- 2023-05-31 KR KR1020230070371A patent/KR20240094973A/ko not_active Ceased
- 2023-05-31 DK DK23176366.5T patent/DK4385509T3/da active
- 2023-05-31 IL IL321404A patent/IL321404A/en unknown
- 2023-05-31 FI FIEP23176366.5T patent/FI4385509T3/fi active
- 2023-05-31 ES ES23176366T patent/ES3055214T3/es active Active
- 2023-05-31 AU AU2023396459A patent/AU2023396459A1/en active Pending
- 2023-05-31 SI SI202330057T patent/SI4385509T1/sl unknown
- 2023-05-31 TW TW112120343A patent/TW202423436A/zh unknown
- 2023-05-31 PL PL23176366.5T patent/PL4385509T3/pl unknown
- 2023-05-31 WO PCT/US2023/067656 patent/WO2024129220A1/en not_active Ceased
- 2023-05-31 LT LTEP23176366.5T patent/LT4385509T/lt unknown
- 2023-05-31 JP JP2023090210A patent/JP7757345B2/ja active Active
- 2023-05-31 SM SM20250453T patent/SMT202500453T1/it unknown
- 2023-05-31 EP EP25199386.1A patent/EP4667050A3/en active Pending
- 2023-05-31 DE DE202023003007.2U patent/DE202023003007U1/de active Active
- 2023-05-31 PT PT231763665T patent/PT4385509T/pt unknown
-
2025
- 2025-06-12 CL CL2025001743A patent/CL2025001743A1/es unknown
- 2025-06-12 MX MX2025006897A patent/MX2025006897A/es unknown
- 2025-07-03 CO CONC2025/0009079A patent/CO2025009079A2/es unknown
- 2025-10-08 JP JP2025169972A patent/JP2026031546A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI222879B (en) | Release-controlled pharmaceutical compositions for treating dysfunction of urinary bladder | |
| KR101718639B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| US6376550B1 (en) | Pharmaceutical compositions containing tramadol for migraine | |
| JP2505944B2 (ja) | （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物 | |
| JPH06102622B2 (ja) | 肥満の治療 | |
| JP2005512995A5 (https=) | ||
| JP2020529996A5 (https=) | ||
| JP2012136523A (ja) | テルビナフィンを含有する医薬組成物およびその使用 | |
| JP2013213047A (ja) | にきびの治療方法発明の分野 | |
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| CN107260695A (zh) | 硝唑尼特的控制释放药物剂型 | |
| JP2001089394A (ja) | 迅速作用性選択的セロトニン再摂取阻害剤を用いた性的不全の処置方法 | |
| JP2021512906A5 (https=) | ||
| JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| JP2022511788A5 (https=) | ||
| SK284937B6 (sk) | Použitie prokineticky účinného antiemetika a tramadolu na výrobu liečiva na liečenie migrény | |
| JP2024531188A5 (https=) | ||
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| RU2261098C2 (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
| RU2002109234A (ru) | Способ лечения нарушений метаболизма, прежде всего диабета или заболеваний или состояний, связанных с диабетом | |
| JP2022177119A5 (https=) | ||
| JP2019533672A5 (https=) | ||
| JP2024084670A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| BRPI0609779A2 (pt) | composição farmacêutica oral de liberação controlada, e, método de tratamento da deficiência de hormÈnio da tireóide |